APA (7th ed.) Citation

RM, M., CMC, M., TG, N., EM, E., CDS, S., LAB, C., . . . MLS, M. (2025). Immunogenicity, safety and immunological memory of a Brazilian meningococcal C conjugate vaccine on a phase II clinical trial. Vaccine, 62, 127419. https://doi.org/10.1016/j.vaccine.2025.127419

Chicago Style (17th ed.) Citation

RM, Martins, et al. "Immunogenicity, Safety and Immunological Memory of a Brazilian Meningococcal C Conjugate Vaccine on a Phase II Clinical Trial." Vaccine 62 (2025): 127419. https://doi.org/10.1016/j.vaccine.2025.127419.

MLA (9th ed.) Citation

RM, Martins, et al. "Immunogenicity, Safety and Immunological Memory of a Brazilian Meningococcal C Conjugate Vaccine on a Phase II Clinical Trial." Vaccine, vol. 62, 2025, p. 127419, https://doi.org/10.1016/j.vaccine.2025.127419.